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Abstract
Objectives—To evaluate the effects of a genetic reduction of Lias gene expression on
atherosclerosis development.
Methods and Results—Heterozygous knockout mice for the lipoid acid synthase gene
(Lias+/−) were crossed with apolipoprotein E–deficient (ApoE−/−) mice, and the plaque size in
aortic sinuses of Lias+/− ApoE−/− mice was evaluated at 6 months of age. Lesions at the aortic
sinus in Lias+/− ApoE−/− males were significantly larger (1.5X) than those in Lias+/+ ApoE−/−
littermate males. The lesion size was inversely correlated with an increased erythrocyte reduced
glutathione/ oxidized glutathione (GSH/GSSH) ratio, an systemic index of body redox balance.
Lias+/− ApoE−/− males also had significantly increased plasma cholesterol and reduced pyruvate
dehydrogenase complex activity in the liver. Significant reductions in the expression of genes for
antioxidant enzymes, including superoxide dismutase 1 (SOD1) and SOD2, were observed in
aortas of Lias+/− ApoE−/− males. Female Lias+/− ApoE−/− also exhibited changes in these
parameters, parallel to those observed in males. However, the Lias gene effects for the majority of
these factors, including atherosclerotic lesion size, were not significant in females.
Conclusions—Our data provide evidence that Lias deficiency enhances atherosclerosis in male
mice, at least in part due to reduce antioxidant capacity. The notable absence of such effects in
females leaves open the possibility of a gender-specific protection mechanism.
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1. Introduction
It is evident that oxidative stress, an imbalance between free radical production and
antioxidant defense, plays an important role in the development of atherosclerosis [1].
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Alpha-lipoic acid (1, 2-dithiolane-3-pentanoic acid, thioctic acid, LA) is a potent sulfur-
containing antioxidant [2]. It is also a cofactor for mitochondrial enzymes such as pyruvate
dehydrogenase complex (PDC) and alpha keto-glutarate dehydrogenase complex (KDC),
both of which participate in glucose metabolism and ATP generation [3]. The presence of
LA in the diet has antioxidant, anti-inflammatory and lipid-decreasing effects, all of which
are known to act as deterrents against atherosclerosis in animal models [4–6]. However,
results in the literature are somewhat conflicting with some studies suggesting that LA also
exhibits pro-oxidant properties [7]. Controversy also persists with regards to plasma
cholesterol, with one set of work suggesting LA acts to reduce the sterol [5,8,9], while
another set reports the absence of any such effect [4,10]. Such discrepancies may stem from
differing routes of LA administration as well as other pharmacokinetic and pharmaceutical
factors. While LA is a chiral compound with two enantiomers, only R-(+)-lipoic acid can
operate as an enzymatic cofactor. This suggests that pure R-(+)-lipoic acid may possess
different pharmaceutical properties compared to those of a racemic mixture. Obviously,
using a genetic model can reduce or avoid extraneous influences such as choice of
administrative route and chirality issues in exogenous LA.
Endogenous production of LA is mediated by lipoic acid synthase (Lias) in mitochondria.
The Lias homozygous knockout mice die in utero shortly after implantation, suggesting
endogenous LA is essential for normal embryo development [11]. Supplementation of
exogenous racemic LA to Lias+/− dams did not rescue embryonic Lias−/− embryos [11]. The
Lias gene expression in many organs of Lias+/− mice is half of that in their wild-type
littermates. Although Lias+/− mice appear normal and healthy, the reactive oxygen species
(ROS) level is significantly increased compared to Lias+/+ littermates under stress
conditions, such as lipopolysaccharide-induced sepsis [12]. These studies clearly indicate
that endogenous antioxidant capacity in Lias+/− mice is reduced.
In this study, we mated Lias+/− mice with ApoE−/− mice to test whether the mice with 50%
normal expression of the Lias gene would increase oxidative stress and lead to more severe
atherosclerosis. Our results showed that the mean areas of aortic plaques in the male
Lias+/−ApoE−/− mice were significantly larger than those in male Lias+/+ApoE−/−
littermates. The larger plaque sizes were accompanied by enhanced oxidative stress,
increased plasma cholesterol, and a transition from glucose to lipid catabolism in the liver.
The majority of parameter trends in the Lias+/−ApoE−/− females, including atherosclerotic
plaque size, were not statistically different from those in the Lias+/+ ApoE−/− females,
although they did exhibit trends in the same direction as the males.
2. Methods
2.1. Animals
ApoE−/− mice on 129/SvEv genetic background [13] were crossed with Lias+/− mice on the
same background [11] to generate the double mutant mice. Both male and female
Lias+/−ApoE−/− mice were employed for our experiments and their littermates
Lias+/+ApoE−/− mice served as controls. Mice were fed normal chow, and were given free
access to water. Mouse experiments were carried out under protocols approved by the
Institutional Animal Care and Use Committee of the University of North Carolina at Chapel
Hill.
2.2. Atherosclerotic Lesion Analysis
Atherosclerotic lesion analyses followed the standard protocol in our laboratory [14]. Frozen
sections of the proximal aorta were stained with Sudan IV and counterstained with
hematoxylin, and the areas of atherosclerotic lesions were measured using NIH 1.59
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Imaging Software. The average lesion area in sections from four anatomically defined
positions was taken as the lesion size of each animal.
2.3. Biochemical Analysis
2.3.1. Plasma parameters—Mice were fasted for 4 hours and then blood samples were
collected from the orbital sinus. Plasma levels of glucose, total cholesterol and triglyceride
(TG) were measured with commercially available kits (Wako, Richmond, VA). Plasma
pyruvate concentrations were examined using the assay kit (BioVision, Inc. Mountain View,
CA). Lactic acid concentrations in tissues were determined as described [15].
2.3.2. Lipoprotein profile—Plasma lipoprotein profiles were determined by fast
performance liquid chromatography (FPLC) chromatography (Amersham Pharmacia
Biotech, Piscataway, NJ), followed by measurement of cholesterol content in each fraction
[14].
2.3.3. Biomarkers of oxidative stress—The redox state of the whole body was
determined as the ratio of reduced glutathione (GSH)/oxidized glutathione (GSSG) in
erythrocytes using an assay kit (Calbiochem, San Diego, CA). Plasma lipid peroxide content
was determined using the thiobarbituric acid reactive substances (TBARS) assay with
malondialdehyde as the standard [11].
2.4. Real-time reverse-transcription polymerase chain reaction
Thoracic aortas (including arch, ascending and descending aorta), and livers were dissected
from 6 month old mice and total RNAs were isolated using an ABI 6700 Automated Nucleic
Acid Workstation following the manufacturer’s protocol (Applied Biosystems, Foster City,
CA). Expression of the genes for Lias, copper/zinc superoxide dismutase (Sod1), manganese
superoxide dismutase (Sod2), and glutathione peroxidase 1 (GPx1) in the aortas, as well as
pyruvate dehydrogenase phosphatase 2 (Pdp2), pyruvate dehydrogenase kinase 3 (Pdk3) and
peroxisome proliferator-activated receptor gamma (PPAR-g), hydroxymethylglutaryl-
coenzyme A reductase (HMG-CoA reductase), cholesterol 7 alpha hydroxylase (CYP7α),
low density lipoprotein receptor (LDLR) and carnitine palmitoyltransferase I α (Cpt 1α) in
the livers, were determined by quantitative real-time RT-PCR with β-actin as the reference
gene in each reaction.
2.5. Isolation of mitochondria
Mitochondria from the liver were isolated as previously described [17] with minor
modifications. Briefly, the liver was excised, minced and homogenized in isolation buffer
consisting of 100 mM Tris/HCl, pH 7.4, 2 mM EDTA, 210 mM mannitol, 70 mM sucrose
and 2 mM dithiothreitol. The homogenate was centrifuged at 600 × g, 10 min, at 4 °C. The
supernatant was centrifuged at 7,000 × g for 10 min, at 4 °C. Mitochondria were washed
twice by re-suspension and centrifugation at 7,000 × g for 10 min, at 4 °C. Following the
final centrifugation, mitochondria were re-suspended in the isolation buffer with protease
inhibitor cocktail (Sigma, St. Louis). Concentrations of mitochondria were determined by
BCA protein assay kit (Thermo Scientific, Rockford, IL) and bovine serum albumin as the
standard.
2.6. Measurement of pyruvate dehydrogenase complex activity
PDC activity was determined in mitochondria isolated from the liver using a PDC Assay Kit
(MitoSciences, Eugene, Oregon) following the manufacture’s instruction.
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2.7. Measurement of apoptosis in aorta plaque
Cell apoptosis in the plaques was examined using TUNEL ApopTag Fluorescein in Situ
Apoptosis Detection Kit (Chemicon International Inc. Billerica, Massachusetts). Freshly cut
cryosections were fixed with 1% paraformaldehyde in PBS (pH 7.4) for 10 minutes at room
temperature, rinsed with PBS and permeabilized with a mixture 2:1 of ethanol and acetic
acid for 5 minutes at −20°C. Slides were incubated with the reaction buffer containing the
TdT enzyme for 1 hour at 37°C in a humidified chamber and then incubated with a FITC-
conjugated anti-digoxigenin antibody for 30 minutes at room temperature. Finally, slides
were mounted with a DAPI/antifade medium. Slides were observed and photographed with
an Olympus BX61 fluorescence microscope (Olympus, Center Valley, PA).
2.8. Statistics
All values are expressed as mean ±S.E. Statistical analysis was carried out using JMP
software (SAS, Cary, NC). Effects of antioxidant status and plasma cholesterol on the lesion
sizes in Lias+/−ApoE−/− and Lias+/+ApoE−/− mice were analyzed by linear regression.
3. Results
3.1. Increased body weight in Lias+/−ApoE−/−Mice
All animals gained weight steadily during the study period. At 6 months, male Lias+/−
ApoE−/− mice were heavier than male Lias+/+ApoE−/− mice by 7.3% (P<0.01). Their food
intake did not differ. Female Lias+/−ApoE−/− mice were also heavier but the difference was
not statistically significant (Table 1).
3.2. Male, but not female, Lias+/−ApoE−/− mice had larger lesions
Atherosclerotic plaques at the aortic sinus of each mouse were histologically analyzed at 6
months of age. Male Lias+/−apoE−/− mice had a 43% increase in atherosclerotic plaque area
compared to male Lias+/+apoE−/− mice (P< 0.001) (Figure 1E). The mean size of lesions at
the aortic sinus was 9.3±0.8 µm2×104 and 6.4±0.6 µm2×104 (P<0.05) in 6-month-old
Lias+/−apoE−/− and Lias+/+apoE−/− males, respectively. In contrast, increases in lesion size
in females were small with no significant difference between the two genotypes. The mean
lesion size at the aortic sinus was 7.7±0.5 µm2×104, and 7.3±0.7µm2×104 in Lias+/−apoE−/−
and Lias+/+apoE−/− females respectively (Figure 1E). However, when both males and
females were analyzed together using two-way ANOVA, the genotype effect was significant
(P<0.05 for genotype effect, P=0.47 for gender effect, and P=0.54 for the interaction).
Plaques in all animals were mature and complex, with fibrous caps, cholesterol clefts and
necrotic lipid cores (Figure 1A through 1D). Apoptotic cells were not detected in the plaques
in the aortic sinus of the 6 month old Lias+/−ApoE−/− or Lias+/+ApoE−/− males.
3.3.Increased plasma cholesterol in Lias+/−apoE−/− mice
At the end of the observed period, total plasma cholesterol levels were significantly higher
in male Lias+/−apoE−/− than in male Lias+/+apoE−/− mice (P<0.05). Plasma cholesterol
levels in female Lias+/−apoE−/− mice were also higher than Lias+/−apoE−/− mice, but the
difference was not statistically significant. Nevertheless, when both genders were analyzed
together by two-way ANOVA, the 50% reduction in Lias gene expression associated with
the Lias+/−ApoE−/− mice increased plasma cholesterol (P<0.01 for the genotype effect,
P=NS for gender effect, and for interaction of these two factors) (Table 1). However, there
was no correlation between plasma cholesterol and the atherosclerotic lesion size in the
individual animals (Figure 2E and 2F). Plasma lipoprotein profile analysis by FPLC showed
that the increased plasma cholesterol in Lias+/−apoE−/− mice was distributed primarily in
Very Low Density Lipoprotein (VLDL) and Intermediate Density Lipoprotein (IDL)
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fractions in both males and females (Figure 2A and 2B). The effect of LA on plasma TG
was not different between the two groups (P=0.08 for effect of genotype effect, P=0.1 for
gender effect, and P=0.9 for interaction) (Table 1).
3.4 Increased oxidative stress in Lias+/−ApoE−/− mice
The systemic redox status of the whole body was estimated by determining the ratio of
GSH/GSSG in erythrocytes. The ratio of GSH/GSSG in Lias+/−ApoE−/− mice was
significantly lower (P<0.05) in males (Figure 2C). The females showed the same trend of
reduction but the difference was not significant. A two-way ANOVA showed that the Lias
genotype effect was significant (P< 0.05). Likewise, levels of plasma TBARS in both male
and female Lias+/−ApoE−/− mice were elevated compared to Lias+/+ApoE−/− mice, but only
the male mice showed statistical significance (Figure 2D). Again, the amount of TBARS
was significantly affected by the genotype when the data from both genders were processed
together by two-way ANOVA (P<0.01 for genotype effect, P=NS for gender effect and for
interaction). Linear regression analysis showed that the ratio of GSH/GSSG was inversely
correlated with atherosclerotic lesion size in individual male mice but not in female mice
(Figure 2G and 2H).
3.5. Altered hepatic metabolism in the Lias+/−ApoE−/− mice
The activity of PDC in male and female Lias+/−ApoE−/− livers was 45% and 55%,
respectively, of those in their WT counterparts (10.1 vs 21.4 and 11.0 vs 20.0 U/mg protein,
Figure 3A). Plasma pyruvate levels in Lias+/−ApoE−/− mice were elevated by about 50% in
both genders (Table 1). Plasma lactate concentrations were not significantly different
between the two genotypes (data not shown). To determine whether the Lias+/− mutation
exerts a regulatory effect on the pyruvate dehydrogenase complex, gene expression of Pdp2,
Pdk3 and Pparg was measured in the liver. The results showed no genotype difference in the
expression of these genes (Supplemental Table 1B).
Expression of the genes for HMG-CoA reductase and Cyp7α did not differ significantly
between the Lias+/−apoE−/− mice and their control counterparts (Supplemental Table 1B).
However, the expression of the Ldlr gene was slightly lower (P=0.07) in the Lias+/−apoE−/−
mice than in the Lias+/+apoE−/− mice, suggesting that the increase in plasma cholesterol
might be due to decreased uptake of lipoproteins by the liver. Finally, liver gene expression
of Cpt1α was significantly increased by 44% in Lias+/−ApoE−/− mice compared with Lias+/
+ApoE−/− mice (Figure 3B).
3.6. Reduced aortic expression of antioxidant enzymes in Lias+/−ApoE−/− males
To determine whether Lias deficiency in Lias+/−ApoE−/− mice influences antioxidant
capacity in the aorta, the expression of genes coding for Lias, Sod1, Sod2 and Gpx-1 was
assessed. Male Lias+/−ApoE−/− aorta showed significantly reduced gene expression of Sod1
and Sod2 (43% and 60%, respectively), compared with Lias+/+ApoE−/− aorta (Figure 3C,
3D). Gpx-1 gene expression in Lias+/−ApoE−/− was also lower but the difference did not
reach statistical significance. The gene expression of interleukin-6 (IL-6), a pro-
inflammatory cytokine, increased 2.4-fold in male Lias+/−ApoE−/− mice and 1.7-fold in
female Lias+/+ApoE−/− mice, but the difference was not statistically significant in either sex
(P=0.11 by ANOVA, Supplemental Table 1A).
4. Discussion
The present study showed that atherosclerotic plaques in male ApoE−/− mice with 50%
normal expression of the Lias gene were modestly, but significantly, larger than those in
ApoE−/− males with the wild type Lias gene. Our genetic model provides evidence for the
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role of endogenous LA in metabolic regulation, cholesterol-lowering and as an antioxidant
and anti-atherogenic molecule. The anti-atherogenic effect of endogenous LA was
accompanied by increased whole body oxidative stress, and reduced expression of genes for
antioxidant enzymes SOD1 and SOD2 in the aorta. This phenomenon may also involve
LA’s anti-inflammatory properties and its regulatory influences over glucose metabolism, as
indicated by increased gene expression of the pro-inflammatory cytokine, IL-6, increased
body weight, and decreased PDC activity in the Lias+/−ApoE−/− mice.
Under normal physiological conditions, excess ROS in the aorta are mainly scavenged by
antioxidant enzymes such as SOD and peroxidase. Increased levels of ROS, including
superoxide and hydrogen peroxide have been reported in atherosclerotic vessel walls [18].
We were concerned whether the mice with 50% normal expression of the Lias gene would
lead to a diminished endogenous antioxidant defense reservoir, as LA is a powerful
antioxidant in addition to being capable of recycling other antioxidants [19]. Since
decreasing mRNA levels usually indicate a decline in production of a protein/enzyme, we
examined antioxidant enzyme gene expression in the whole aorta to evaluate local
antioxidant capacity. We found that Sod1 and Sod2 mRNA levels were significantly
decreased in the aorta of Lias+/−ApoE−/− male mice, compared to those of Lias+/+ApoE−/−
mice. The causative relationships between the reduced Sod1/Sod2 expression and
atherosclerosis, however, are far from simple. For instance, Heon et al. reported that the
mRNA levels of many antioxidant enzyme genes, including Sod1 and Sod2, in late stages of
atherosclerosis were reduced as the animals aged and plaque size increased [20]. They also
showed that in the period preceding visible lesion formation, mRNA levels of the
antioxidant enzymes in the aortic arch of ApoE−/− mice were higher than those in age-
matched wild-type mice [20]. Thus, the decreased Sod1 and Sod2 expression in the aortas of
Lias+/−ApoE−/− mice could be due to increased plaque development. However, we found no
correlation between the expression levels of these genes and plaque sizes in individual
animals. Instead, we observed that the ratio of GSH/GSSG in erythrocytes, an index of total
body antioxidant capacity, was markedly reduced in male Lias+/−ApoE−/− mice and its
reduction was inversely correlated with aortic lesion size in individual animals. Taken
together, these observations strongly suggest that oxidative stress is one of the mechanisms
underlying the increased atherosclerosis in the male Lias+/−ApoE−/− mice.
Increased plasma cholesterol is known to be a major risk factor related to the development
of atherosclerosis [21]. However, the effect of exogenous LA on plasma cholesterol levels in
animal models has produced conflicting data [4,5,8–10]. Plasma cholesterol levels are
significantly higher in Lias+/−ApoE−/− mice than Lias+/+ApoE−/− mice, although linear
regression analysis indicates that a high plasma cholesterol level is not a major contributing
factor to atherosclerosis development in our animals. To explore the mechanism whereby
LA influences plasma cholesterol, we examined changes in gene expression relevant to
cholesterol metabolism. The gene expression of HMG-CoA reductase, the rate limiting step
for cholesterol synthesis; CYP7α, the first rate-limiting step of bile acid synthesis from
cholesterol, did not vary considerably between Lias+/− ApoE−/− mice and Lias+/+ApoE−/−
mice. However, gene expression for LDLR in Lias+/− ApoE−/− mice was slightly reduced,
suggesting that reduced lipoprotein uptake might at least in part contribute to the increased
plasma cholesterol levels in Lias+/−ApoE−/− mice. Another plausible mechanism is that LA
suppresses appetite [22], resulting in reduced dietary intake of cholesterol. Although food
intake was not significantly different, Lias+/− ApoE−/− mice gained more weight. This is
consistent with the body weight reducing effects of exogenous LA [16,22]. Thus, this effect,
combined with the overall change in metabolic state, may contribute to the plasma
cholesterol increase in the presence of Lias deficiency. Like the reports regarding the effects
of LA on plasma cholesterol levels, reports of its effect on plasma triglyceride (TG) are also
conflicting [4]. These differences could depend on the chiralic nature of LA, dose, diet and/
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or other unknown factors. The differences could also come from distinct functions between
endogenous and exogenous LA in metabolic pathways, such as increased fatty acid
oxidation.
Our data also indicate that LA may participate in regulating an interaction between oxidative
stress and PDC activity. PDC works as a critical link between glycolysis and the Krebs
cycle, catalyzing the oxidative decarboxylation of pyruvate to form acetyl CoA as part of
aerobic glucose metabolism. The strict cofactor requirements and stringent regulation of
PDC make it vulnerable during diseases [23]. PDC is known to be targeted and even
inactivated by ROS, and one PDC subunit, dihydrolipoyl transacetylase (E2) (where lipoic
acid covalently binds), is particularly susceptible to impairment [3]. Since exogenous LA is
synthesized by Lias from octanoic acid moiety attached to subunits E2 of PDC as substrates,
exogenous LA may not be incorporated into the apoenzyme [11]. Nevertheless, even if
exogenous LA does not directly function as a cofactor of mitochondrial enzymes, a
substantial reduction of oxidative stress likely facilitates overall cellular metabolism. The
PDC complex is regulated by phosphoryl covalent modification, being inactivated by PDH
kinase and activated by PDH phophatase. However, our data from the gene expression
analysis of Pdp2 and Pdk3 exclude the possibility that the decline in PDC activity is
regulated by LA through altered synthesis of the two modifying enzymes. Reduced PDC
activity in the Lias+/−ApoE−/− mice most likely, therefore, is the direct consequence of Lias
deficiency in the mitochondria. Increased Cpt1α gene expression in Lias+/−ApoE−/− livers
suggests a compensatory increase in the usage of fatty acids as an energy source. These
metabolic changes, combined with a decrease in antioxidant capacity, could lead to
mitochondrial damage which has been thought to associate with development of
atherosclerotic plaques. Further investigation will be necessary to determine whether a 50%
reduction in Lias expression is sufficient to cause mitochondrial dysfunction in cells such as
macrophages, smooth muscle cells and endothelial cells, and can contribute to the
development of atherosclerosis. We also note that pyruvate can function as an antioxidant
and reduce lipid peroxide to lipid hydroxide [24]. However, increased plasma pyruvate was
not sufficient to overcome the deficiency in overall antioxidant capacity in the
Lias+/−ApoE−/− mice.
One important finding of our experiments is that a significant increase the severity of
atherosclerosis was not detected in female mice. Interestingly, all the differences observed in
males were also present in females, although the differences were less significant or not
significant. Thus, the effect of a 50% reduction in Lias gene expression appears to be
dampened in females compared to males. This suggests the presence of a female-specific
protection mechanism against the consequences of reduced LA. The basis for this gender
difference is not fully understood, but recent clinical and experimental data suggest that
levels of vascular ROS during normal physiological conditions may be lower in females
than males [25]. Reduced production of ROS may mask the genotype effects of LA in
females. It is also possible that sex hormones such as estrogen enhance the normal
antioxidant capacity in females. The gender difference in oxidative stress and antioxidant
activities could, therefore, account for the non-significance in the atherosclerotic plaque size
we observed in female Lias+/−ApoE−/− compared to Lias+/+ApoE−/− mice.
In conclusion, our genetic model provides evidence that a reduction in endogenous lipoic
acid modestly increases atherosclerosis in atherosclerosis-prone male mice, and this
acceleration was strongly correlated with a reduction in the antioxidant capacity.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Representative light photomicrographs of aortic roots of Lias+/− (A and C) and Lias+/+ mice
(B and D) on an ApoE−/− background. Sections are stained with Sudan IV and
counterstained with hematoxylin. (E) Atherosclerotic plaque sizes at the aortic roots of 6-
month-old male and female Lias+/−ApoE−/− mice (filled circles) and Lias+/+ApoE−/− mice
(open circles). Each dot represents the mean lesion size of 4 sections in each mouse in log
scale. Horizontal bars with numbers indicate antilog of log means. The numbers of the dots
indicate animal numbers per group.
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(A and B) Plasma lipoprotein profiles separated by fast performance liquid chromatography
(FPLC) in Lias+/−ApoE−/− mice (black dots) and Lias+/+ApoE−/− mice (white dots).
Cholesterol was determined by measurement of an aliquot of each fraction. (C and D)
General oxidative stress markers in Lias+/−ApoE−/− mice (black bars) and Lias+/+ApoE−/−
mice (white bars) at 6 months of age. (C) Ratio of erythrocyte reduced glutathione (GSH)/
oxidized glutathione (GSSG). (D) Plasma thiobarbituric acid reactive substances (TBARS).
The numbers inside bars indicate number of animals. Results are expressed as mean ± SEM.
(E, F, G, and H) Simple linear regression analysis between plasma cholesterol and lesion
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size of aortic roots (E and F), and between ratio of GSH/GSSG in erythrocyte and lesion size
(G and H) in Lias+/−ApoE−/− (black squares) and Lias+/+ApoE−/− mice (white squares).
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(A) Activity of pyruvate dehydrogenase complex in the livers of Lias+/−ApoE−/− and
Lias+/+ApoE−/− mice at 6 months of age. (B) Gene expression of carnitine palmitoyl
transferase-1α in liver. (C and D) Gene expression of Sod1 (C) and Sod2 (D) in aorta.
mRNA levels are expressed relative to the mean levels of the mRNA in the male
Lias+/+ApoE−/− as 100%. Results are expressed as mean ± SEM. White bars represent
Lias+/−ApoE−/− mice and black bars stand for Lias+/+ApoE−/− mice. Numbers inside bars
indicate number of animals.
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